Simon Cartmell

Simon Cartmell is a seasoned healthcare executive with extensive experience in the pharmaceutical, biotech, and medical technology industries. He served as the CEO of ApaTech Ltd, a bone replacement specialist company that was acquired by Baxter International in 2010.12

Career Highlights

ApaTech Ltd: Cartmell led ApaTech as its CEO, guiding the company to significant growth. Under his leadership, ApaTech:

• Developed and commercialized Actifuse, a synthetic bone graft material
• Achieved sales of approximately $60 million in 2009
• Was acquired by Baxter International for up to $330 million in 20102

Other Notable Positions:

• Chairman at OssDsign AB (since 2016)
• Director at BONE SUPPORT AB (since 2018)
• Chief Executive Officer at various companies including Entomed SA and Calon Cardio-Technology Ltd
• Executive and non-executive roles at numerous healthcare and technology firms1

Expertise and Contributions

Cartmell has over 30 years of experience in the healthcare sector, specializing in:

• Pharmaceutical and biotech product development
• Medical technology commercialization
• Venture capital and business development in the healthcare industry3

His leadership at ApaTech was particularly noteworthy, as he developed the business into a global leader in its field over a seven-year period.4

Education

Cartmell received his:

• Undergraduate degree from The University of Manchester
• Graduate degree from the University of London1

Simon Cartmell's extensive experience and successful track record in the healthcare industry, particularly his tenure as CEO of ApaTech Ltd, have established him as a respected figure in the medical technology sector.